UK Colorectal Cancer drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for colorectal cancer drugs is expanding due to various reasons like increase incidence and prevalence of colorectal cancer cases, increase awareness about the disease, globally ageing population. Mortality due to colorectal cancer, rising medical tourism in developing countries and benefits offered by generic medicines are other reasons. Bristol-Myer Squibb, Merck, Sanofi, Eli Lilly, Bayer are the top key market players in Global Colorectal Cancer drugs Market.
UK Colorectal Cancer Drugs Market is valued at around $0.36 Bn in 2022 and is projected to reach $0.42 Bn by 2030, exhibiting a CAGR of 2.1% during the forecast period 2023-2030.
The colorectal cancer drugs market includes all the drugs and therapies which are used to treat and manage colorectal cancer. Adjuvant/neoadjuvant medicines for treatment are also included in the market. Colorectal cancer (CRC) also known as Bowel cancer, affects the large intestine and the rectum. They are also called colon tumours or rectal cancer, depending on where they start. Vascular endothelial growth factor (VEGF) inhibitors, epidermal growth factor receptor (EGFR) inhibitors, programmed cell death protein 1/PD1 ligand (PD1/PDL1) inhibitors, BRAF or MEK inhibitors, tyrosine kinase (TKI) inhibitors, and immunomodulators are the main categories of colorectal cancer medications. Drugs that inhibit the function of VEGF and VEGFR are known as vascular endothelial growth factors (VEGF). Chemotherapy, immunotherapy, and other medication groups are among them. Chemotherapy's market share is anticipated to decline due to its non-specificity, side effects, and the emergence of chemical agent resistance. Increasing use of targeted therapies and biologicals is going to be the new trend in the market. Hormone treatments, gene expression regulators, apoptosis-inducing agents, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules are examples of target therapies. Due to its selectivity towards cancer cells, while minimising harm to off-target cells, targeted therapy is becoming increasingly important. Instead of using chemical medications that weaken the body's immune system, biological therapy harnesses the body's immune system to fight cancer. Pharmaceutical and biotechnology firms like Eli Lilly and Company, Roche, Merck & Co., Pfizer, Sanofi, and Novartis, are some of the major players in the market.
Market Drivers
Colorectal cancer awareness- An increase in awareness about colorectal cancer and thus new product introductions are market-driving factors.
Rising Incidence and Prevalence- Colorectal cancer is one of the most widespread and costly cancers in the world. The need for colorectal cancer medications is driven by the rising incidence and prevalence of colorectal cancer, which results in a sizable patient population needing efficient therapies.
Globally ageing population- As the ageing population is increasing global incidence of colorectal cancer cases also increases.
Rising medical tourism in developing countries- Medical tourism is increasing in developing countries which is also increasing the market in these countries.
Mortality due to colorectal cancer – This increases the R and D in the development of new drugs.
Government initiatives and funding- Health organisations and governments all over the world are recognising the impact of colorectal cancer and the demand for better therapies. They are putting plans in place to increase knowledge, enhance early diagnosis, and give financing for colorectal cancer therapy research and development.
Benefits offered by generic drugs in colorectal cancer treatment are also a driving factor
Market Restraints
High development costs: New treatments require significant research, preclinical studies, and stringent clinical trials in colorectal drug development.
Increase use of biologicals and targeted therapies acts as a restraint for conventional chemotherapy drugs.
Key players
Merck & Co. Bristol-Myers Squibb Pfizer AstraZeneca Johnson & Johnson Roche Sanofi Takeda Pharmaceutical Company Eli Lilly and Company Amgen1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Therapy:
By Cancer type:
By Distribution Channels:
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?